Condition: Schizophrenia · Sponsor: Bristol-Myers Squibb
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Pillar Clinical Research- Little Rock | Little Rock, Arkansas, United States | Recruiting |
| Clinical Innovations, Inc. dba CITrials | Bellflower, California, United States | Recruiting |
| CenExel CNS - Garden Grove | Garden Grove, California, United States | Recruiting |
| ATP Clinical Research | Orange, California, United States | Recruiting |
| Innovative Clinical Research | Lauderhill, Florida, United States | Recruiting |
| Health Synergy Clinical Research | West Palm Beach, Florida, United States | Recruiting |
| Uptown Research Institute | Chicago, Illinois, United States | Recruiting |
| Pillar Clinical Research -Chicago | Chicago, Illinois, United States | Recruiting |
| IMA Clinical Research Las Vegas | Las Vegas, Nevada, United States | Recruiting |
| Hassman Research Institute Marlton Site | Marlton, New Jersey, United States | Recruiting |
| Adams Clinical Philadelphia | Philadelphia, Pennsylvania, United States | Recruiting |
| Local Institution - 0001 | Austin, Texas, United States | Not Yet Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.